Patient Monitoring Global Market – Forecast To 2020
Patient monitoring market is mounting as a result of advancement in upcoming technologies that is providing an excellent opportunity for cultivating improvised care for patients across every corner of the globe. Patient monitoring system involves continuous/semi-continuous measurement of patient’s physiological parameters such as heart rate, respiratory rate, blood pressure, core temperatures and pulse oximetry etc., which accelerates patient’s quality care by making superior clinical-decision. Patient monitoring plays a fundamental role in emergency and operating rooms, intensive and critical care units by reducing onset of complications and risks in patient. It is proven to be very useful in respiratory therapy, recovery rooms, out-patient care, transport, radiology, cath labs, gastroenterology departments, ambulatory, home, and sleep screening applications.
Patient monitoring devices market is mainly divided into following segments such as by-devices, by-end-users. Patient Monitoring market by-devices are classified into cardiac monitors, fetal, prenatal and neonatal monitors, hemodynamic monitors, multi-parameter monitors, neurological monitors, respiratory monitors, remote patient monitors, micro electromechanical systems-based monitors, temperature and weight monitors. PM market by-end-users are divided into medical centers and medical specialist, primary healthcare and community healthcare centers, laboratories and diagnostic centers and home-based users.
Patient monitoring devices are requisite part of medical team for every procedure i.e. operating in a clinic or multi specialty hospitals. The reduction in size of the monitors over the years through contemporary technologies and rising adoption of telemetry and remote monitoring has increased the growth of the patient monitoring devices. Cardiac monitoring segment commanded the largest share in global patient monitoring market for 2013 and is expected to maintain its strong share by 2019. Multi-parameter monitoring is the second largest share holder in the market. Moreover, respiratory monitoring and neurological monitors is the fastest growing segments due to rising incidence of respiratory and neuro-degenerative diseases and demand for portable devices.
The global patient monitoring devices market is expected to reach approximately $24,353 million by 2020 growing at CAGR of around 5.2%. Geographically, North America commands the largest share and is expected to record a healthy market share by $9,681 million by 2020. APAC is going to be one of the prominent regions for this market in coming years driven by healthcare awareness, high purchasing power and rising population.
Patient monitoring devices market is mainly divided into following segments such as by-devices, by-end-users. Patient Monitoring market by-devices are classified into cardiac monitors, fetal, prenatal and neonatal monitors, hemodynamic monitors, multi-parameter monitors, neurological monitors, respiratory monitors, remote patient monitors, micro electromechanical systems-based monitors, temperature and weight monitors. PM market by-end-users are divided into medical centers and medical specialist, primary healthcare and community healthcare centers, laboratories and diagnostic centers and home-based users.
Patient monitoring devices are requisite part of medical team for every procedure i.e. operating in a clinic or multi specialty hospitals. The reduction in size of the monitors over the years through contemporary technologies and rising adoption of telemetry and remote monitoring has increased the growth of the patient monitoring devices. Cardiac monitoring segment commanded the largest share in global patient monitoring market for 2013 and is expected to maintain its strong share by 2019. Multi-parameter monitoring is the second largest share holder in the market. Moreover, respiratory monitoring and neurological monitors is the fastest growing segments due to rising incidence of respiratory and neuro-degenerative diseases and demand for portable devices.
The global patient monitoring devices market is expected to reach approximately $24,353 million by 2020 growing at CAGR of around 5.2%. Geographically, North America commands the largest share and is expected to record a healthy market share by $9,681 million by 2020. APAC is going to be one of the prominent regions for this market in coming years driven by healthcare awareness, high purchasing power and rising population.
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACK DOWN & DATA TRIANGULATION
2.5.3 SECONDARY RESEARCH RESOURCES
2.5.4 PRIMARY RESEARCH RESOURCES
2.5.5 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing geriatric population and rising incidences of lifestyle diseases
3.3.1.2 Rise in sales of remote monitoring systems favoring reduced healthcare expenditure
3.3.1.3 Advancement of new technologies and less staff usage
3.3.1.4 Expansion of point-of-care devices
3.3.1.5 Emerging markets and low cost manufacturers
3.3.1.6 Advancement in wireless and sensor technologies
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Financial crisis
3.3.2.2 High pricing of devices
3.3.2.3 Reimbursement issues
3.3.2.4 Uncertain return of investment (ROI)
3.3.3 BURNING ISSUES
3.3.3.1 Thermal injuries caused by devices
3.3.4 WINNING IMPERATIVE
3.3.4.1 Wireless technology adoption at lower cost
3.4 PORTER’S FIVE FORCE ANALYSIS
3.4.1 THREAT OF NEW ENTRANTS
3.4.2 THREAT OF SUBSTITUTES
3.4.3 RIVARLY AMONG EXISTING COMPETITORS
3.4.4 BARGAINING POWER OF SUPPLIERS
3.4.5 BARGAINING POWER OF BUYERS
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN
3.6 MARKET SHARE ANALYSIS
3.7 UPCOMING TECHNOLOGIES
3.8 WEARABLE DEVICES
3.8.1 SOME OF THE RECENT WEARABLE DEVICES ARE:
3.9 OLDER ADULT PATIENT MONITORING DEVICES
3.9.1 SOME OF THE DEVICES USED BY OLDER ADULTS
4 GLOBAL PATIENT MONITORING SYSTEM MARKET, BY DEVICE
4.1 INTRODUCTION
4.2 CARDIAC MONITORS
4.2.1 ELECTROCARDIOGRAM
4.2.2 EVENT MONITOR
4.2.3 CARDIAC OUTPUT MONITOR
4.2.4 HOLTER MONITOR
4.2.5 IMPLANTable LOOP RECORDER
4.3 HEMODYNAMIC MONITORS
4.3.1 BLOOD PRESSURE MONITORS
4.3.2 BLOOD GLUCOSE MONITORS
4.3.2.1 Single point blood glucose monitors
4.3.2.2 Continuous glucose monitoring devices
4.3.3 BLOOD GAS AND ELECTROLYTE ANALYZERS
4.4 MULTI-PARAMETER MONITORS
4.4.1 LOW ACUITY
4.4.2 MID ACUITY
4.4.3 HIGH ACUITY
4.5 NEUROLOGICAL MONITORS
4.5.1 ELECTROENCEPHALOGRAM
4.5.2 TRANSCRANIAL DOPPLER
4.5.3 MAGNETOENCEPHALOGRAPH
4.5.4 CEREBRAL OXIMETRY MONITORS
4.5.5 INTRACRANIAL PRESSURE MONITORS
4.6 PRENATAL, FETAL AND NEONATAL MONITORS
4.6.1 ULTRASOUND AND ULTRASONOGRAPHY
4.6.2 FETAL DOPPLER
4.6.3 FETAL MAGNETIC RESONANCE IMAGING
4.6.4 FETAL MONITORS
4.6.5 INFANT WARMERS AND INCUBATORS
4.6.6 PHOTOTHERAPY EQUIPMENT
4.6.7 NEONATAL MONITORING DEVICE
4.6.8 RESPIRATORY ASSISTANCE AND MONITORING DEVICES
4.7 RESPIRATORY MONITORING DEVICES
4.7.1 CAPNOGRAPHS
4.7.2 SPIROMETER
4.7.3 ANESTHESIA MONITORS
4.7.4 SLEEP APNEA MONITORS
4.7.5 PULSE OXIMETERS
4.8 REMOTE PATIENT MONITORING DEVICES
4.8.1 HEMODYNAMIC MONITORING DEVICES
4.8.2 NEUROMONITORING DEVICES
4.8.3 CARDIAC MONITORING DEVICES
4.8.4 MULTI-PARAMETER MONITORING DEVICES
4.8.5 OTHERS
4.9 MICRO-ELECTROMECHANICAL SYSTEMS
4.9.1 ACCELEROMETERS
4.9.2 GYROSCOPES
4.9.3 PRESSURE SENSORS
4.9.4 CHEMICAL AND GAS SENSORS
4.9.5 THERMAL IR SENSORS
4.9.6 OPTICAL MEMS
4.9.7 RF MEMS
4.9.8 MICROFLUIDIC CHIPS
4.9.9 SILICON MICROPHONES
4.9.10 OTHERS
4.10 TEMPERATURE MONITORING DEVICES
4.10.1 MERCURY-FILLED THERMOMETERS
4.10.2 DIGITAL THERMOMETERS
4.10.3 INFRARED THERMOMETERS
4.10.4 THERMOMETER STRIPS
4.11 WEIGHT MONITORING DEVICES
5 GLOBAL PATIENT MONITORING SYSTEM MARKET, BY END-USERS
5.1 INTRODUCTION
5.2 MEDICAL CENTRE AND MEDICAL SPECIALIST
5.3 PRIMARY HEALTHCARE AND COMMUNITY HEALTHCARE CENTER
5.4 LABORATORIES AND DIAGNOSTIC CENTERS
5.5 HOME-BASED USERS
6 REGIONAL MARKET ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.3 EUROPE
6.4 ASIA-PACIFIC
6.5 REST OF THE WORLD
7 COMPANY DEVELOPMENTS
7.1 INTRODUCTION
7.1.1 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES AS A MAJOR GROWTH STRATEGY OF PATIENT MONITORING PLAYERS
7.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
7.3 NEW PRODUCT LAUNCH
7.4 EXPANSION
7.5 MERGERS AND ACQUISITIONS
7.6 APPROVALS
8 MAJOR COMPANY PROFILES
8.1 ABBOTT LABORATORIES
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 BOSTON SCIENTIFIC CORPOARTION
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 COVIDIEN PLC
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 GE HEALTHCARE
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 JOHNSON & JOHNSON
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 MEDTRONIC INC.
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 OMRON HEALTHCARE, INC.
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 PHILIPS HEALTHCARE
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 ROCHE LTD.
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 ST. JUDE MEDICAL, INC.
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACK DOWN & DATA TRIANGULATION
2.5.3 SECONDARY RESEARCH RESOURCES
2.5.4 PRIMARY RESEARCH RESOURCES
2.5.5 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing geriatric population and rising incidences of lifestyle diseases
3.3.1.2 Rise in sales of remote monitoring systems favoring reduced healthcare expenditure
3.3.1.3 Advancement of new technologies and less staff usage
3.3.1.4 Expansion of point-of-care devices
3.3.1.5 Emerging markets and low cost manufacturers
3.3.1.6 Advancement in wireless and sensor technologies
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Financial crisis
3.3.2.2 High pricing of devices
3.3.2.3 Reimbursement issues
3.3.2.4 Uncertain return of investment (ROI)
3.3.3 BURNING ISSUES
3.3.3.1 Thermal injuries caused by devices
3.3.4 WINNING IMPERATIVE
3.3.4.1 Wireless technology adoption at lower cost
3.4 PORTER’S FIVE FORCE ANALYSIS
3.4.1 THREAT OF NEW ENTRANTS
3.4.2 THREAT OF SUBSTITUTES
3.4.3 RIVARLY AMONG EXISTING COMPETITORS
3.4.4 BARGAINING POWER OF SUPPLIERS
3.4.5 BARGAINING POWER OF BUYERS
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN
3.6 MARKET SHARE ANALYSIS
3.7 UPCOMING TECHNOLOGIES
3.8 WEARABLE DEVICES
3.8.1 SOME OF THE RECENT WEARABLE DEVICES ARE:
3.9 OLDER ADULT PATIENT MONITORING DEVICES
3.9.1 SOME OF THE DEVICES USED BY OLDER ADULTS
4 GLOBAL PATIENT MONITORING SYSTEM MARKET, BY DEVICE
4.1 INTRODUCTION
4.2 CARDIAC MONITORS
4.2.1 ELECTROCARDIOGRAM
4.2.2 EVENT MONITOR
4.2.3 CARDIAC OUTPUT MONITOR
4.2.4 HOLTER MONITOR
4.2.5 IMPLANTable LOOP RECORDER
4.3 HEMODYNAMIC MONITORS
4.3.1 BLOOD PRESSURE MONITORS
4.3.2 BLOOD GLUCOSE MONITORS
4.3.2.1 Single point blood glucose monitors
4.3.2.2 Continuous glucose monitoring devices
4.3.3 BLOOD GAS AND ELECTROLYTE ANALYZERS
4.4 MULTI-PARAMETER MONITORS
4.4.1 LOW ACUITY
4.4.2 MID ACUITY
4.4.3 HIGH ACUITY
4.5 NEUROLOGICAL MONITORS
4.5.1 ELECTROENCEPHALOGRAM
4.5.2 TRANSCRANIAL DOPPLER
4.5.3 MAGNETOENCEPHALOGRAPH
4.5.4 CEREBRAL OXIMETRY MONITORS
4.5.5 INTRACRANIAL PRESSURE MONITORS
4.6 PRENATAL, FETAL AND NEONATAL MONITORS
4.6.1 ULTRASOUND AND ULTRASONOGRAPHY
4.6.2 FETAL DOPPLER
4.6.3 FETAL MAGNETIC RESONANCE IMAGING
4.6.4 FETAL MONITORS
4.6.5 INFANT WARMERS AND INCUBATORS
4.6.6 PHOTOTHERAPY EQUIPMENT
4.6.7 NEONATAL MONITORING DEVICE
4.6.8 RESPIRATORY ASSISTANCE AND MONITORING DEVICES
4.7 RESPIRATORY MONITORING DEVICES
4.7.1 CAPNOGRAPHS
4.7.2 SPIROMETER
4.7.3 ANESTHESIA MONITORS
4.7.4 SLEEP APNEA MONITORS
4.7.5 PULSE OXIMETERS
4.8 REMOTE PATIENT MONITORING DEVICES
4.8.1 HEMODYNAMIC MONITORING DEVICES
4.8.2 NEUROMONITORING DEVICES
4.8.3 CARDIAC MONITORING DEVICES
4.8.4 MULTI-PARAMETER MONITORING DEVICES
4.8.5 OTHERS
4.9 MICRO-ELECTROMECHANICAL SYSTEMS
4.9.1 ACCELEROMETERS
4.9.2 GYROSCOPES
4.9.3 PRESSURE SENSORS
4.9.4 CHEMICAL AND GAS SENSORS
4.9.5 THERMAL IR SENSORS
4.9.6 OPTICAL MEMS
4.9.7 RF MEMS
4.9.8 MICROFLUIDIC CHIPS
4.9.9 SILICON MICROPHONES
4.9.10 OTHERS
4.10 TEMPERATURE MONITORING DEVICES
4.10.1 MERCURY-FILLED THERMOMETERS
4.10.2 DIGITAL THERMOMETERS
4.10.3 INFRARED THERMOMETERS
4.10.4 THERMOMETER STRIPS
4.11 WEIGHT MONITORING DEVICES
5 GLOBAL PATIENT MONITORING SYSTEM MARKET, BY END-USERS
5.1 INTRODUCTION
5.2 MEDICAL CENTRE AND MEDICAL SPECIALIST
5.3 PRIMARY HEALTHCARE AND COMMUNITY HEALTHCARE CENTER
5.4 LABORATORIES AND DIAGNOSTIC CENTERS
5.5 HOME-BASED USERS
6 REGIONAL MARKET ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.3 EUROPE
6.4 ASIA-PACIFIC
6.5 REST OF THE WORLD
7 COMPANY DEVELOPMENTS
7.1 INTRODUCTION
7.1.1 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES AS A MAJOR GROWTH STRATEGY OF PATIENT MONITORING PLAYERS
7.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
7.3 NEW PRODUCT LAUNCH
7.4 EXPANSION
7.5 MERGERS AND ACQUISITIONS
7.6 APPROVALS
8 MAJOR COMPANY PROFILES
8.1 ABBOTT LABORATORIES
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 BOSTON SCIENTIFIC CORPOARTION
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 COVIDIEN PLC
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 GE HEALTHCARE
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 JOHNSON & JOHNSON
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 MEDTRONIC INC.
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 OMRON HEALTHCARE, INC.
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 PHILIPS HEALTHCARE
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 ROCHE LTD.
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 ST. JUDE MEDICAL, INC.
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 2 PATIENT MONITORING MARKET REVENUE, BY DEVICES (2012-2020) ($MN)
Table 3 CARDIAC MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 4 CARDIAC MONITORING DEVICE MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 5 ELECTROCARDIOGRAPH MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 6 EVENT MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 7 CARDIAC OUTPUT MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 8 HOLTER MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 9 IMPLANTable LOOP RECORDER MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 10 HEMODYNAMIC MONITORS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 11 HEMODYNAMIC MONITORS GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 12 MERCURY-FREE BLOOD PRESSURE MONITORS
Table 13 BLOOD PRESSURE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 14 BLOOD GLUCOSE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 15 BLOOD GAS & ELECTROLYTE ANALYZER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 16 MULTI-PARAMETER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 17 MULTI-PARAMETER GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 18 LOW ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 19 MID ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 20 HIGH ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 21 NEUROLOGICAL MONITORS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 22 NEUROLOGICAL MONITORS GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 23 ELECTROENCEPHALOGRAPH GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 24 TRANSCRANIAL DOPPLER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 25 MAGNETOENCEPHAOLOGRAPH GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 26 CEREBRAL OXIMETRY MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 27 INTRACRANIAL PRESSURE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 28 PRENATAL, FETAL & NEONATAL MONITORING DEVICE MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 29 PRENATAL, FETAL & NEONATAL MONITORING DEVICE MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 30 ULTRASOUND & ULTRASONOGRAPHY MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 31 FETAL DOPPLER MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 32 FETAL MAGNETIC RESONANCE IMAGING MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 33 FETAL MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 34 INFANT WARMER & INCUBATOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 35 PHOTOTHERAPY EQUIPMENT MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 36 NEONATAL MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 37 RESPIRATORY ASSISTANCE & MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 38 RESPIRATORY PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 39 RESPIRATORY PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 40 CAPNOGRAPHS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 41 SPIROMETERS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 42 ANESTHESIA PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 43 SLEEP APNEA PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 44 PULSE OXIMETERS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 45 REMOTE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 46 REMOTE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 47 HEMODYNAMIC REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 48 NEURO REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 49 CARDIAC REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 50 MULTI-PARAMETER REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 51 OTHER REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 52 MICRO-ELECTROMECHANICAL SYSTEMS (MEMS) PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 53 MEMS PATIENT MONITORING GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 54 ACCELEROMETER MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 55 GYROSCOPE MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 56 PRESSURE SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 57 CHEMICAL AND GAS SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 58 THERMAL IR SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 59 OPTICAL MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 60 RF MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 61 MICROFLUIDIC CHIP MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 62 SILICON MICROPHONE MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 63 OTHER MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 64 TEMPERATURE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 65 TEMPERATURE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 66 MERCURY-FILLED THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 67 DIGITAL THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 68 INFRARED THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 69 TEMPERATURE STRIP PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 70 WEIGHT PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 71 PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 72 MEDICAL CENTRE AND MEDICAL SPECIALIST GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 73 PRIMARY HEALTHCARE AND COMMUNITY HEALTHCARE CENTER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 74 LABORATORIES AND DIAGNOSTIC CENTER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 75 HOME-BASED USER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 76 PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 77 NORTH AMERICAN PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN)
Table 78 NORTH AMERICAN CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 79 NORTH AMERICAN PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 80 NORTH AMERICAN HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 81 NORTH AMERICAN MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 82 NORTH AMERICAN NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 83 NORTH AMERICAN RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 84 NORTH AMERICAN REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 85 NORTH AMERICAN MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 86 NORTH AMERICAN TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 87 NORTH AMERICAN PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 88 EUROPEAN PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN)
Table 89 EUROPEAN CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 90 EUROPEAN PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 91 EUROPEAN HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 92 EUROPEAN MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 93 EUROPEAN NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 94 EUROPEAN RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 95 EUROPEAN REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 96 EUROPEAN MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 97 EUROPEAN TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 98 EUROPEAN PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 99 ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN)
Table 100 ASIA-PACIFIC CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 101 ASIA-PACIFIC PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 102 ASIA-PACIFIC HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 103 ASIA-PACIFIC MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 104 ASIA-PACIFIC NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 105 ASIA-PACIFIC RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 106 ASIA-PACIFIC REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 107 ASIA-PACIFIC MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 108 ASIA-PACIFIC TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 109 ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 110 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN)
Table 111 ROW CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 112 ROW PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 113 ROW HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 114 ROW MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 115 ROW NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 116 ROW RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 117 ROW REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 118 ROW MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 119 ROW TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 120 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 121 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2012-2014)
Table 122 NEW PRODUCT LAUNCHES (2012-2014)
Table 123 EXPANSION (2012-2014)
Table 124 MERGERS AND ACQUISITIONS (2014)
Table 125 APPROVALS (2013 - 2014)
Table 126 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN)
Table 127 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 128 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN)
Table 129 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 130 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN)
Table 131 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 132 COVIDIEN PLC: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 133 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN)
Table 134 COVIDIEN PLC: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 135 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND R&D EXPENSES (2011 – 2013) ($BN)
Table 136 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($BN)
Table 137 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2011-2013) ($BN)
Table 138 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES 2011-2013 ($ BN)
Table 139 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 140 JOHNSON & JOHNSON: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY SEGMENTS(2011-2013) ($BN)
Table 141 JOHNSON & JOHNSON: GEOGRAPHICAL REVENUE, BY REGION (2011-2013) ($BN)
Table 142 MEDTRONIC INC.: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($MN)
Table 143 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN)
Table 144 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($MN)
Table 145 OMRON: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN)
Table 146 OMRON.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 147 OMRON: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN)
Table 148 PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN)
Table 149 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 150 PHILIPS N.V.: HEALTHCARE BUSINESS REVENUE (2011-2013) ($BN)
Table 151 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN)
Table 152 ROCHE LTD.: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($BN)
Table 153 ROCHE LTD.: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($BN)
Table 154 ROCHE LTD.: DIAGNOSTICS REVENUE, BY SEGMENTS, (2011-2013) ($BN)
Table 155 ROCHE LTD.: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN)
Table 156 ST. JUDE MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENSES (2011-13) ($BN)
Table 157 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY SEGMENT (2011-13) ($BN)
Table 158 ST. JUDES MEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY (2011-13) ($BN)
Table 1 PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 2 PATIENT MONITORING MARKET REVENUE, BY DEVICES (2012-2020) ($MN)
Table 3 CARDIAC MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 4 CARDIAC MONITORING DEVICE MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 5 ELECTROCARDIOGRAPH MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 6 EVENT MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 7 CARDIAC OUTPUT MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 8 HOLTER MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 9 IMPLANTable LOOP RECORDER MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 10 HEMODYNAMIC MONITORS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 11 HEMODYNAMIC MONITORS GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 12 MERCURY-FREE BLOOD PRESSURE MONITORS
Table 13 BLOOD PRESSURE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 14 BLOOD GLUCOSE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 15 BLOOD GAS & ELECTROLYTE ANALYZER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 16 MULTI-PARAMETER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 17 MULTI-PARAMETER GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 18 LOW ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 19 MID ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 20 HIGH ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 21 NEUROLOGICAL MONITORS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 22 NEUROLOGICAL MONITORS GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 23 ELECTROENCEPHALOGRAPH GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 24 TRANSCRANIAL DOPPLER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 25 MAGNETOENCEPHAOLOGRAPH GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 26 CEREBRAL OXIMETRY MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 27 INTRACRANIAL PRESSURE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 28 PRENATAL, FETAL & NEONATAL MONITORING DEVICE MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 29 PRENATAL, FETAL & NEONATAL MONITORING DEVICE MARKET REVENUE, BY TYPE (2012-2020) ($MN)
Table 30 ULTRASOUND & ULTRASONOGRAPHY MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 31 FETAL DOPPLER MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 32 FETAL MAGNETIC RESONANCE IMAGING MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 33 FETAL MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 34 INFANT WARMER & INCUBATOR MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 35 PHOTOTHERAPY EQUIPMENT MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 36 NEONATAL MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 37 RESPIRATORY ASSISTANCE & MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 38 RESPIRATORY PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 39 RESPIRATORY PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 40 CAPNOGRAPHS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 41 SPIROMETERS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 42 ANESTHESIA PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 43 SLEEP APNEA PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 44 PULSE OXIMETERS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 45 REMOTE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 46 REMOTE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 47 HEMODYNAMIC REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 48 NEURO REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 49 CARDIAC REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 50 MULTI-PARAMETER REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 51 OTHER REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 52 MICRO-ELECTROMECHANICAL SYSTEMS (MEMS) PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 53 MEMS PATIENT MONITORING GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 54 ACCELEROMETER MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 55 GYROSCOPE MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 56 PRESSURE SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 57 CHEMICAL AND GAS SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 58 THERMAL IR SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 59 OPTICAL MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 60 RF MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 61 MICROFLUIDIC CHIP MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 62 SILICON MICROPHONE MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 63 OTHER MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 64 TEMPERATURE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 65 TEMPERATURE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 66 MERCURY-FILLED THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 67 DIGITAL THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 68 INFRARED THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 69 TEMPERATURE STRIP PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 70 WEIGHT PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 71 PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 72 MEDICAL CENTRE AND MEDICAL SPECIALIST GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 73 PRIMARY HEALTHCARE AND COMMUNITY HEALTHCARE CENTER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 74 LABORATORIES AND DIAGNOSTIC CENTER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 75 HOME-BASED USER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN)
Table 76 PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN)
Table 77 NORTH AMERICAN PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN)
Table 78 NORTH AMERICAN CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 79 NORTH AMERICAN PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 80 NORTH AMERICAN HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 81 NORTH AMERICAN MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 82 NORTH AMERICAN NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 83 NORTH AMERICAN RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 84 NORTH AMERICAN REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 85 NORTH AMERICAN MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 86 NORTH AMERICAN TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 87 NORTH AMERICAN PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 88 EUROPEAN PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN)
Table 89 EUROPEAN CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 90 EUROPEAN PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 91 EUROPEAN HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 92 EUROPEAN MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 93 EUROPEAN NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 94 EUROPEAN RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 95 EUROPEAN REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 96 EUROPEAN MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 97 EUROPEAN TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 98 EUROPEAN PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 99 ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN)
Table 100 ASIA-PACIFIC CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 101 ASIA-PACIFIC PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 102 ASIA-PACIFIC HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 103 ASIA-PACIFIC MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 104 ASIA-PACIFIC NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 105 ASIA-PACIFIC RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 106 ASIA-PACIFIC REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 107 ASIA-PACIFIC MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 108 ASIA-PACIFIC TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 109 ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 110 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN)
Table 111 ROW CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 112 ROW PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 113 ROW HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 114 ROW MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 115 ROW NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 116 ROW RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 117 ROW REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 118 ROW MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 119 ROW TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN)
Table 120 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN)
Table 121 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2012-2014)
Table 122 NEW PRODUCT LAUNCHES (2012-2014)
Table 123 EXPANSION (2012-2014)
Table 124 MERGERS AND ACQUISITIONS (2014)
Table 125 APPROVALS (2013 - 2014)
Table 126 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN)
Table 127 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 128 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN)
Table 129 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 130 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN)
Table 131 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 132 COVIDIEN PLC: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN)
Table 133 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN)
Table 134 COVIDIEN PLC: TOTAL REVENUE, BY REGION (2011-2013) ($MN)
Table 135 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND R&D EXPENSES (2011 – 2013) ($BN)
Table 136 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($BN)
Table 137 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2011-2013) ($BN)
Table 138 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES 2011-2013 ($ BN)
Table 139 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 140 JOHNSON & JOHNSON: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY SEGMENTS(2011-2013) ($BN)
Table 141 JOHNSON & JOHNSON: GEOGRAPHICAL REVENUE, BY REGION (2011-2013) ($BN)
Table 142 MEDTRONIC INC.: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($MN)
Table 143 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN)
Table 144 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($MN)
Table 145 OMRON: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN)
Table 146 OMRON.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 147 OMRON: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN)
Table 148 PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN)
Table 149 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN)
Table 150 PHILIPS N.V.: HEALTHCARE BUSINESS REVENUE (2011-2013) ($BN)
Table 151 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN)
Table 152 ROCHE LTD.: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($BN)
Table 153 ROCHE LTD.: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($BN)
Table 154 ROCHE LTD.: DIAGNOSTICS REVENUE, BY SEGMENTS, (2011-2013) ($BN)
Table 155 ROCHE LTD.: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN)
Table 156 ST. JUDE MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENSES (2011-13) ($BN)
Table 157 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY SEGMENT (2011-13) ($BN)
Table 158 ST. JUDES MEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY (2011-13) ($BN)
LIST OF FIGURES
Figure 1 GLOBAL PATIENT MONITORING MARKET SHARE, BY GEOGRAPHY (2012-2020)
Figure 2 RESEARCH METHODOLOGY: PATIENT MONITORING MARKET
Figure 3 PATIENT MONITORING MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 PATIENT MONITORING MARKET: FORECASTING MODEL
Figure 5 PATIENT MONITORING MARKET: MARKET CRACKDOWN & DATA TRIANGULATION
Figure 6 GLOBAL PATIENT MONITORING DEVICE MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 PATIENT MONITORING DEVICES: PORTER’S ANALYSIS
Figure 9 GLOBAL PATIENT MONITORING DEVICES MARKET SHARE ANALYSIS, BASED ON MARKET REVENUE, 2013
Figure 10 GLOBAL PATIENT MONITORING DEVICE, MARKET SHARE VS CAGR (2012 – 2020)
Figure 11 CARDIAC MONITORING MARKET SHARE (2013 VS 2020)
Figure 12 NEUROLOGICAL MARKET SHARE: 2013 VS 2020
Figure 13 RESPIRATORY MONITORS MARKET SHARE 2013 VS 2020
Figure 14 REMOTE PATIENT MONITORING MARKET SHARE 2013 VS 2020
Figure 15 PATIENT MONITORING MARKET REVENUE: BY ENDUSERS
Figure 16 GLOBAL PATIENT MONITORING SCENARIO, BY REGION, 2012 – 2020 ($MN)
Figure 17 NORTH AMERICA PATIENT MONITORING MARKET REVENUE BY DEVICES (2013)
Figure 18 EUROPEAN PM’S MARKET REVENUE BY DEVICES
Figure 19 ASIA PACIFIC PATIENT MONITORING MARKET REVENUE BY DEVICES
Figure 20 ROW PATIENT MONITORING MARKET REVENUE BY DEVICES
Figure 21 KEY GROWTH STRATEGIES, (2012 – 2014)
Figure 22 SWOT: ABBOTT LABORATORIES INC
Figure 23 SWOT ANALYSIS: BOSTON SCIENTIFIC
Figure 24 SWOT: COVIDIEN PLC
Figure 25 SWOT: GE HEALTHCARE
Figure 26 SWOT: JOHNSON & JOHNSON
Figure 27 SWOT: MEDTRONIC
Figure 28 SWOT: OMRON HEALTHCARE INC
Figure 29 SWOT: PHILIPS HEALTHCARE
Figure 30 SWOT ANALYSIS: ROCHE DIAGNOSTICS
Figure 31 SWOT: ST JUDE MEDICAL
Figure 1 GLOBAL PATIENT MONITORING MARKET SHARE, BY GEOGRAPHY (2012-2020)
Figure 2 RESEARCH METHODOLOGY: PATIENT MONITORING MARKET
Figure 3 PATIENT MONITORING MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 PATIENT MONITORING MARKET: FORECASTING MODEL
Figure 5 PATIENT MONITORING MARKET: MARKET CRACKDOWN & DATA TRIANGULATION
Figure 6 GLOBAL PATIENT MONITORING DEVICE MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 PATIENT MONITORING DEVICES: PORTER’S ANALYSIS
Figure 9 GLOBAL PATIENT MONITORING DEVICES MARKET SHARE ANALYSIS, BASED ON MARKET REVENUE, 2013
Figure 10 GLOBAL PATIENT MONITORING DEVICE, MARKET SHARE VS CAGR (2012 – 2020)
Figure 11 CARDIAC MONITORING MARKET SHARE (2013 VS 2020)
Figure 12 NEUROLOGICAL MARKET SHARE: 2013 VS 2020
Figure 13 RESPIRATORY MONITORS MARKET SHARE 2013 VS 2020
Figure 14 REMOTE PATIENT MONITORING MARKET SHARE 2013 VS 2020
Figure 15 PATIENT MONITORING MARKET REVENUE: BY ENDUSERS
Figure 16 GLOBAL PATIENT MONITORING SCENARIO, BY REGION, 2012 – 2020 ($MN)
Figure 17 NORTH AMERICA PATIENT MONITORING MARKET REVENUE BY DEVICES (2013)
Figure 18 EUROPEAN PM’S MARKET REVENUE BY DEVICES
Figure 19 ASIA PACIFIC PATIENT MONITORING MARKET REVENUE BY DEVICES
Figure 20 ROW PATIENT MONITORING MARKET REVENUE BY DEVICES
Figure 21 KEY GROWTH STRATEGIES, (2012 – 2014)
Figure 22 SWOT: ABBOTT LABORATORIES INC
Figure 23 SWOT ANALYSIS: BOSTON SCIENTIFIC
Figure 24 SWOT: COVIDIEN PLC
Figure 25 SWOT: GE HEALTHCARE
Figure 26 SWOT: JOHNSON & JOHNSON
Figure 27 SWOT: MEDTRONIC
Figure 28 SWOT: OMRON HEALTHCARE INC
Figure 29 SWOT: PHILIPS HEALTHCARE
Figure 30 SWOT ANALYSIS: ROCHE DIAGNOSTICS
Figure 31 SWOT: ST JUDE MEDICAL
